wegovy glp 1 agonist Pill vs. Foundayo: Which Oral GLP-1 Is Better for Weight Loss? POTD: Wegovy and Ozempic —

Triple-Hormone-Receptor Agonist Retatrutide for ObesityA Phase 2 Trial

The findings add to growing evidence that obesity behaves like a chronic disease rather than a short-term condition that can be permanently reversed after temporary treatment

Multiple GLP-1 medications have been approved by the FDA for weight loss and management

SS attended scientific advisory committee meetings or received speaking fees from AstraZeneca, Atara, Boehringer Ingelheim, Bristol-Myers-Squibb, Covis, Novartis, Panalgo, Pfizer, CSL Behring, and Covispharma, all unrelated to this study

Introduction Obesity poses a significant burden to individual and public health [1]